Syntheses, Crystal Structures and DNA-binding Properties of Cd(Ⅱ), Co(Ⅱ), Cu(Ⅱ) and Zn(Ⅱ) Complexes Containing Imidazolium Derivatives

Yu-Han LI Yu YANG Hui-Chao GUAN Min ZHANG Lin-Lin XU Shu-Mei YUE

Citation:  Yu-Han LI, Yu YANG, Hui-Chao GUAN, Min ZHANG, Lin-Lin XU, Shu-Mei YUE. Syntheses, Crystal Structures and DNA-binding Properties of Cd(Ⅱ), Co(Ⅱ), Cu(Ⅱ) and Zn(Ⅱ) Complexes Containing Imidazolium Derivatives[J]. Chinese Journal of Structural Chemistry, 2020, 39(2): 356-367. doi: 10.14102/j.cnki.0254–5861.2011–2633 shu

Syntheses, Crystal Structures and DNA-binding Properties of Cd(Ⅱ), Co(Ⅱ), Cu(Ⅱ) and Zn(Ⅱ) Complexes Containing Imidazolium Derivatives

English

  • In recent years, metal complexes exhibited advantages in light, electricity, magnetism, biology, etc. They have become a kind of functional complexes that have been paid extensive attention to and studied[1-7]. Imidazole derivatives with good biological activity can be used as insecticides and bactericides in organisms[8-11]. Imidazolium can coordinate with many metal ions, which is the focus of researches on imidazolium complexes in recent years[12, 13]. Mohammad Y. Alfaif et al reported that the new imidazolyl palladium(Ⅱ) Saldach complex has obvious binding ability to CT-DNA[14]. Zhou Qing-Hua et al reported imidazole Cu(Ⅱ) and Mn(Ⅱ) complexes in 2005, and the interaction between complexes and calf thymus DNA was investigated[15, 16]. For it can provide valuable information in the development of drugs, phosphate bond can be hydrolyzed quickly under the action of imidazolium complexes of manganese(Ⅱ). It is expected to be applied as an effective reagent for hydrolyzing and cutting DNA[15]. Although many such researches have been studied, some controversy in studying the interaction between metal complexes and DNA still exists[17-19]. The special structure of DNA has large and small grooves, negatively charged phosphate skeleton and stacked base pairs. The bonding sites and interaction modes between metal complexes and DNA are determined. There are three main modes of interaction between metal complexes and DNA: non-covalent combination, covalent combination and cutting[20]. Now the non-covalent interactions between drug molecules and DNA reported contained electrostatic binding, grooving binding and intercalation interaction. If complexes that can target DNA destruction are found, anti-cancer drugs and cancer treatment will be further developed[21-24].

    In the most recent years, our research group has been working hardly on the synthesis of benzothiazole and benzimidazole metal complexes, in addition to their properties[25-27]. Qi Shuang et al. reported a success in synthesizing the metal complexes of Zn(Ⅱ), Co(Ⅱ) and Ni(Ⅱ) with 2-(2-pyridyl) benzothiazole as ligands in 2018. Besides, a study was performed of the binding properties exhibited by the complexes with DNA[28].

    In this paper, four metal complexes based on 2-(2-pyridyl)benzimidazolium were synthesized and their interaction with DNA was studied. We hope this study can provide potential strategy for the research of anti-cancer.

    All chemicals of reagent grade were obtained from commercial sources and used without further purification. 4, 4΄-Oxybisbenzoic acid was purchased from Aladdin, CT-DNA from Sigma and stored at 2~8 ℃, and tris-buffer from GENVIEW used for the preparation of all solutions for CT-DNA binding studies. UV-vis spectral measurements for the synthesized complexes were made using a TU-1901 double beam recording spectrophotometer. Fluorescence spectra were performed on a RF-5301PC fluorescence spectrofluorometer. Viscosity measurements were performed using an Ubbelohde viscometer, which was immersed in a thermostat water bath at 20 ℃.

    A mixture of Cd(NO3)2·4H2O (0.0308 g, 0.1 mmol), H2odc (0.0258 g, 0.1 mmol) and pbm (0.0195 g, 0.1 mmol) was added to DMF (8 mL) and H2O (2 mL), and placed in a Teflon reactor (20 mL) and heated at 80 ℃ for 3 days. After gradually cooling down to room temperature at a rate of 10 ℃·h-1, colorless crystals of complex 1 were obtained with 41% yield based on pbm. Anal. Calcd. (%) for C26H17CdN3O5: C, 55.34; H, 2.70; N, 7.68. Found (%): C, 55.60; H, 2.69; N, 7.52.

    Synthesis of [Co(pbm)(odc)2] (2)

    Complex 2 was synthesized following the same synthetic procedure as that of complex 1 except that CoCl2·6H2O (0.0238 g, 0.1 mmol) was used instead of Cd(NO3)2·4H2O. Red crystals of complex 2 were obtained with 52% yield based on pbm. Anal. Calcd. (%) for C26H17CoN3O5: C, 55.42; H, 2.71; N, 7.73. Found (%): C, 55.53; H, 2.73; N, 7.76.

    Synthesis of [Cu(pbm)(odc)2] (3)

    Complex 3 was synthesized following the same synthetic procedure as that of complex 1 except that Cd(NO3)2·4H2O was substituted by CuCl2·2H2O (0.0171 g, 0.1 mmol). Green crystals of complex 3 were obtained with 43% yield based on pbm. Anal. Calcd. (%) for C26H17CuN3O5: C, 57.66; H, 3.61; N, 8.37. Found (%): C, 57.62; H, 3.57; N, 8.35.

    Synthesis of [Zn(pbm)(odc)2] (4)

    The ZnCl2·2H2O (0.0175 g, 0.1 mmol), H2odc (0.0258 g, 0.1 mmol), and pbm (0.0195 g, 0.1 mmol) were added to methanol (2 mL), DMF (5 mL) and H2O (2 mL), and then placed in a Teflon reactor (20 mL) and heated at 80 ℃ for 3 days. After gradually cooling down to room temperature at a rate of 10 ℃·h-1, colorless crystals of complex 4 were obtained with 41% yield based on pbm. Anal. Calcd. (%) for C26H17ZnN3O5: C, 55.21; H, 2.68; N, 7.74. Found (%): C, 55.14; H, 2.66; N, 7.71.

    Single-crystal XRD data for complexes 1~4 were recorded on a Bruker Apex CCD diffractometer with graphite-monochromatized Mo radiation (λ = 0.71073 Å). Absorption corrections were applied using the multi-scan technique. All the structures were solved by direct methods of SHELXS-97 and refined with ShelXL-97 refinement package using the least-squares minimization[29, 30]. The detailed crystallographic data and structure refinement parameters for 1~4 are summarized in Table 1.

    Table 1

    Table 1.  Crystal Data and Structure Refinement for 1~4
    DownLoad: CSV
    Complexes 1 2 3 4
    CCDC 1924089 1938100 1938101 1924090
    Chemical formula C26H17CdN3O5 C26H17CoN3O5 C26H17CuN3O5 C26H17N3O5Zn
    Temperature (K) 296.15 173.0 187.49 293(2)
    Mr 563.82 510.35 514.96 516.79
    Crystal system Monoclinic Monoclinic Monoclinic Monoclinic
    Space group P21/n P21/n P21/c P21/n
    a (Å) 7.4963(4) 7.3081(9) 13.1636(10) 7.4336(8)
    b (Å) 18.3015(10) 18.501(3) 15.3767(10) 18.470(2)
    c (Å) 16.5769(9) 16.257(2) 11.3600(8) 16.2706(18)
    α (º) 90 90 90 90
    β (º) 98.3510(10) 99.310(5) 100.141(4) 99.863(2)
    γ (º) 90 90 90 90
    Volume (Å3) 2250.1(2) 2169.0(5) 2263.5 2200.9(4)
    Z 4 4 4 4
    Dc (g·cm-3) 1.664 1.563 1.511 1.560
    F(000) 1128.0 1044.0 1052.0 1056.0
    2θ range for data collection 5.69 to 51.424 5.536 to 50.12 8.924 to 130.15 3.36 to 49.364
    Reflections collected/unique 13616/4273(Rint = 0.0610) 21572/3835(Rint = 0.0881) 13027/3757(Rint = 0.0532) 12201/3754(Rint = 0.1168)
    Goodness-of-fit on F2 1.027 1.055 1.129 1.020
    Final R indexes (I > 2σ(I)) R = 0.0518, wR = 0.1222 R = 0.0624, wR = 0.1293 R = 0.0851, wR = 0.1790 R = 0.0667, wR = 0.1717
    Final R indexes (all data) R = 0.0918, wR = 0.1417 R = 0.0927, wR = 0.1428 R = 0.1106, wR = 0.1942 R = 0.1639, wR = 0.2547

    DNA binding experiments which include Ultraviolet spectrum, fluorescence spectrum and viscosity measurements conformed to the standard methods and practices previously adopted by our laboratory[31]. While measuring the absorption and fluorescence spectra, an increasing amount of CT-DNA was added to the complex solution. Viscosity measurements were carried on an Ubbelohde viscometer in a thermostated water-bath maintained at 20 ℃ by varying the concentration of the added metal complexes. The concentration ratio of the sample is shown in Table 2.

    Table 2

    Table 2.  Concentration Ratio of the Mixed Solution
    DownLoad: CSV
    Material number Tris (μL) DNA(μL) Complex (μL)
    1 2700 0 300
    2 2400 300 300
    3 2100 600 300
    4 1800 900 300
    5 1500 1200 300
    6 1200 1500 300

    Single-crystal X-ray diffraction analyses indicate that complex 1 crystallizes in monoclinic space group P21/n. The asymmetric unit of 1 consists of one crystallographically unique Cd(Ⅱ) atom, one pbm ligand and two odc2− anions. As shown in Fig. 1, the Cd(Ⅱ) atom is six-coordinated by two nitrogen atoms from one pbm ligand and four oxygen atoms from two 4, 4΄-oxybisbenzoic acids. The twisted octahedral structure is formed through the geometry around the Cd(Ⅱ) center. The Cd–O bond lengths are in the range of 2.256(4) to 2.372(4) Å, with the average to be 2.314 Å (Table 3). The odc2− anion connects two Cd(Ⅱ) atoms through two chelate carboxylates. The pbm ligand acts as a linker to join one Cd(Ⅱ) atom. The Cd(Ⅱ) atoms are also bridged by the organic ligands into a 2D sql layer (Fig. 2).

    Figure 1

    Figure 1.  Molecular structure of complex 1 at 50% displacement ellipsoids

    Table 3

    Table 3.  Selected Bond Lengths (Å) and Bond Angles (°) of Complexes 1~4
    DownLoad: CSV
    Complex 1 Complex 2 Complex 3 Complex 4
    Bond Dist. Bond Dist. Bond Dist. Bond Dist.
    Cd(1)–O(1) 2.256(4) Co(1)–O(1) 2.142(3) Cu(1)–O(1) 1.856(5) Zn(1)–O(1) 2.132(6)
    Cd(1)–O(2) 2.286(4) Co(1)–O(2) 2.108(3) Cu(1)–O(4)#1 2.092(6) Zn(1)–O(2) 2.158(7)
    Cd(1)–O(4)#1 2.372(4) Co(1)–O(4)#1 2.202(3) O(1)–Cu(1A)#2 1.684(7) Zn(1)–O(4)#1 2.145(6)
    Cd(1)–O(5)#1 2.307(4) Co(1)–O(5)#1 2.126(3) O(5)–Cu(1A)#2 2.408(7) Zn(1)–O(5)#1 2.247(7)
    Cd(1)–N(1) 2.369(6) Co(1)–N(1) 2.169(5) Cu(1)–N(1) 2.051(6) Zn(1)–N(1) 2.045(7)
    Cd(1)–N(2) 2.236(5) Co(1)–N(2) 2.046(4) Cu(1)–N(2) 1.966(7) Zn(1)–N(3) 2.216(9)
    Angle (°) Angle (°) Angle (°) Angle (°)
    C(13)–O(1)–Cd(1) 91.1(4) C(13)–O(1)–Co(1) 87.8(3) C(13)–O(1)–Cu(1) 102.9(4) C(1)–O(1)–Zn(1) 90.1(6)
    C(13)–O(2)–Cd(1) 89.8(4) C(13)–O(2)–Co(1) 89.4(3) C(26)–O(4)–Cu(1)#2 99.3(5) C(1)–O(2)–Zn(1) 88.2(6)
    C(1)–N(1)–Cd(1) 126.4(5) C(1)–N(1)–Co(1) 129.0(4) N(1)–Cu(1)–O(4)#1 163.7(3) C(15)–N(1)–Zn(1) 136.6(7)
    C(5)–N(1)–Cd(1) 114.7(4) C(5)–N(1)–Co(1) 113.7(3) C(5)–N(1)–Cu(1) 113.2(3) C(21)–N(1)–Zn(1) 114(6)
    C(6)–N(2)–Cd(1) 113.8(4) C(6)–N(2)–Co(1) 113.0(3) C(1)–N(1)–Cu(1) 126.8(3) C(22)–N(3)–Zn(1) 112.5(7)
    C(7)–N(2)–Cd(1) 137.5(4) C(7)–N(2)–Co(1) 138.8(3) C(6)–N(2)–Cu(1) 112.0(10) C(26)–N(3)–Zn(1) 128.7(7)
    O(1)–Cd(1)–N(1) 117.74(16) O(1)–Co(1)–N(1) 92.03(15) C(7)–N(2)–Cu(1) 142.3(6) O(1)–Zn(1)–N(3) 109.7(3)
    O(2)–Cd(1)–N(1) 93.88(17) O(2)–Co(1)–N(1) 105.96(14) O(1)–Cu(1)–N(1) 92.1(2) O(2)–Zn(1)–N(3) 91.9(3)
    O(2)–Cd(1)–N(1) 93.88(17) N(2)–Co(1)–O(1) 159.98(15) O(1)–Cu(1)–N(2) 153.5(2) N(1)–Zn(1)–O(1) 102.7(3)
    N(2)–Cd(1)–O(2) 155.42(18) N(2)–Co(1)–O(2) 103.22(15) N(2)–Cu(1)–N(1) 81.6(3) N(1)–Zn(1)–O(2) 156.7(3)
    N(2)–Cd(1)–N(1) 72.96(18) N(2)–Co(1)–N(1) 78.38(16) C(6)–N(2)–C(7) 105.6(10) N(1)–Zn(1)–N(3) 77.5(3)
    O(1)–Cd(1)–O(2) 57.63(15) O(2)–Co(1)–O(1) 62.24(12) C(8)–N(3)–C(6) 106.8(9) O(1)–Zn(1)–O(2) 61.1(3)

    Figure 2

    Figure 2.  Packing diagram of complex 1 in a unit cell viewed along the a axis

    Single-crystal X-ray diffraction analyses indicate that complex 2 crystallizes in monoclinic space group P21/n. The asymmetric unit of 2 consists of one crystallographically unique Co(Ⅱ) atom, one pbm ligand and two odc2− anions. As shown in Fig. 3, the Co(Ⅱ) atom is six-coordinated by two nitrogen atoms from one pbm ligand and four oxygen atoms from two 4, 4΄-oxybisbenzoic acids. The twisted octahedral structure is formed through the geometry around the Co(Ⅱ) center. The Co–O bond lengths fall in the range of 2.108(3)~2.202(3) Å, with an average value of 2.155 Å (Table 3). The odc2− anion connects two Co(Ⅱ) atoms through two chelate carboxylates. The pbm ligand acts as a linker to join one Co(Ⅱ) atom. The Co(Ⅱ) atoms are also bridged by the organic ligands into a 2D sql layer (Fig. 4).

    Figure 3

    Figure 3.  Molecular structure of complex 2 at 50% displacement ellipsoids

    Figure 4

    Figure 4.  Packing diagram of complex 2 in a unit cell viewed along the a axis

    Single-crystal X-ray diffraction analyses indicate that complex 3 crystallizes in monoclinic space group P21/c. The asymmetric unit of 3 consists of one crystallographically unique Cu(Ⅱ) atom, one pbm ligand and two odc2− anions. As shown in Fig. 5, the Cu(Ⅱ) atom is six-coordinated by two nitrogen atoms from one pbm ligand and four oxygen atoms from two 4, 4΄-oxy bisbenzoic acids. The twisted octahedral structure is formed through the geometry around the Cu(Ⅱ) center. The Cu–O bond lengths change from 1.684(7) to 2.408(7) Å, with the average to be 2.046 Å (Table 3). The odc2− anion connects two Cu(Ⅱ) atoms through two chelate carboxylates. The pbm ligand acts as a linker to join one Cu(Ⅱ) atom. The Cu(Ⅱ) atoms are also bridged by the organic ligands into a 2D sql layer (Fig. 6).

    Figure 5

    Figure 5.  Molecular structure of complex 3 at 50% displacement ellipsoids

    Figure 6

    Figure 6.  Packing diagram of complex 3 in a unit cell viewed along the c axis

    Single-crystal X-ray diffraction analyses indicate that complex 4 crystallizes in monoclinic space group P21/n. The asymmetric unit of 4 consists of one crystallographically unique Zn(Ⅱ) atom, one pbm ligand and two odc2− anions. As shown in Fig. 7, the Zn(Ⅱ) atom is six-coordinated by two nitrogen atoms from one pbm ligand and four oxygen atoms from two 4, 4΄-oxy bisbenzoic acids. The twisted octahedral structure is formed through the geometry around the Zn(Ⅱ) center. The Zn–O bond lengths are in the 2.132(6)~2.247(7) Å range, with the average being 2.189 Å (Table 3). The odc2− anion connects two Zn(Ⅱ) atoms through two chelate carboxylates. The pbm ligand acts as a linker to join one Zn(Ⅱ) atom. The Zn(Ⅱ) atoms are also bridged by the organic ligands into a 2D sql layer (Fig. 8).

    Figure 7

    Figure 7.  Molecular structure of complex 4 at 50% displacement ellipsoids

    Figure 8

    Figure 8.  Packing diagram of complex 4 in a unit cell viewed along the a axis
    3.2.1   Thermal analysis

    The thermal stabilities of complexes 1~4 were investigated by thermogravimetric analyses (TGA) measurement (Fig. 9). The experiments were performed on samples consisting of numerous single crystals of 1~4 under N2 atmosphere with a heating rate of 10 ℃/min. For complex 1, no obvious weight loss was observed before the decomposition of the framework which occurred at ca. 417 ℃, with the remaining weight corresponding to the formation of CdO (Calcd.: 22.8%; Found: ca. 24.2%). For 2, the framework decomposed at ca. 394 ℃. The remaining weight corresponds to the formation of CoO (Calcd.: 14.7%; Found: ca. 14.6%). For 3, two stages of weight loss happened. At about ca. 533 ℃, the organic composition in 3 was decomposed completely, and the remaining weight results from the formation of CuO (Calcd.: 15.4%; Found: ca. 18.2%). For 4, the destruction of the framework occurs at ca. 423 ℃, with the remaining weight corresponding to the formation of ZnO (Calcd.: 15.8%; Found: ca. 19.8%).

    Figure 9

    Figure 9.  TG curves of complexes 1~4
    3.2.2   XRD analysis

    The experimental and simulated powder XRD spectra of complexes 1~4 are shown in Fig. 10. The experimental powder XRD pattern for each complex is in accordance with the simulated one generated on the basis of the structural data, confirming the pure phase for the as-synthesized product.

    Figure 10

    Figure 10.  Simulated and experimental XRPD patterns of complexes 1~4

    Ultraviolet absorption spectroscopy is one of the common and effective methods in studying the interaction between complexes and DNA. Usually covalent combination from the interaction between the complex and DNA existed if the absorption peak of the complex decreases and the wavelength red shifts after adding DNA to the solution of the complex[32-34]. If the interaction between the complex and DNA is electrostatic or grooved, the absorption peak of the complex will show a small red-shift, but the color reduction effect is not obvious[35]. When the interaction between the complex and DNA occurred, if the absorption peak is enhanced, the degree of color enhancement is proportional to the concentration of DNA. This may be due to the interaction between the complex and DNA, which leads to the destruction of double helix structure of DNA[36, 37]. Fig. 11 shows the absorption spectra of complexes 1~4 under different DNA concentrations. Strong absorption bands at 283 and 294 nm were observed in complexes 1, 2, 4 and complex 3 respectively. The maximum absorption peak of the complex enhanced as the increased DNA concentration addition, but no red- or blue-shift occurred obviously. Therefore, these changes indicated that the interaction between the complex and DNA is electrostatic or grooved, or probably induced by the destruction of the double helix structure of DNA.

    Figure 11

    Figure 11.  Absorption spectra of (a) [Cd(pbm)(odc)2], (b) [Co(pbm)(odc)2], (c) [Cu(pbm)(odc)2] and (d) [Zn(pbm)(odc)2] in tris-HCl buffer (pH 7.0) in the absence and presence of increasing the amount of DNA at room temperature. Inset: arrow shows change in intensity with increasing the concentration of DNA

    Fluorescence spectroscopy for the emission was conducted to study fluorescent targeting complexes in order to further explore the interaction mode between the complex and DNA. The interaction mode of the two complexes can be judged from the variation of fluorescence intensity before and after interaction[38, 39]. The fluorescence spectra of complexes 1~4 changed with the increase of DNA concentration, as shown in Fig. 12. The complexes exhibited strong fluorescence at 392 nm when excited at 240 nm at room temperature. When the concentration of DNA is gradually increased in the fixed concentration of complex solution, the fluorescence emission intensity increases, but no red- or blue-shift was observed in the emission band, which indicates that the complex has a strong interaction with DNA. The increase of emission intensity may be related to the change of environment and the degree of entry of the complex into the hydrophobic environment of DNA. This not only avoids the quenching effect of solvent water molecules, but also limits the fluidity of complexes at the binding site, thus reducing their vibration modes and enhancing their emission intensity[40].

    Figure 12

    Figure 12.  Emission spectra of (a) [Cd(pbm)(odc)2], (b) [Co(pbm)(odc)2], (c) [Cu(pbm)(odc)2] and (d) [Zn(pbm)(odc)2] in tris-HCl buffer (pH 7.0) in the presence and absence of CT-DNA at room temperature. Arrow shows change in intensity with increasing the concentration of DNA

    The viscosity method plays a unique role in determining the mode of action of metal complexes and DNA, which is the most effective approach to confirm whether complexes and DNA are inserted in an intercalated manner or not, and the results measured by this method are more convincing than that by spectrometry force[41]. When the complex interacts with DNA in the insertion mode, the distance between the base pairs will become larger to accommodate the incoming ligand, resulting in the elongation of DNA double helix and increase of solution viscosity when the complex is electrostatically charged. However, the combination of non-insertion modes, such as groove bonding and electrostatic interaction, bends the DNA helix, and shortens the length of DNA, resulting in negligible change in DNA viscosity at different concentrations[42, 43]. The viscosity curve of the interaction between complexes 1~4 and DNA is shown in Fig. 13. As shown in this figure, the four viscosity curves fluctuate up and down a straight line respectively. Therefore, the interaction mode between the four complexes and DNA is groove binding or electrostatic interaction, which is consistent with that of spectral analysis.

    Figure 13

    Figure 13.  Relative viscosity of CT-DNA upon addition of increasing the amounts of complexes 1~4 (r = 0.0~1.0). η is the viscosity of DNA in the presence of complex, and η0 is the viscosity of DNA alone

    In this study, four new complexes were synthesized successfully under solvothermal conditions with 2-(2-pyridyl)benzimidazole as the main ligand and 4, 4΄-oxybisbenzoic acid as the auxiliary ligand, and their crystal structures were studied. The CT-DNA binding with four new complexes were investigated by absorption, fluorescence spectroscopy and viscosity measurements. The results of this study show that these complexes can probably bind to CT-DNA by electrostatic or grooved mode. These findings have potential value for the study of anticancer drug and DNA replication. We hope to provide valuable information for the study of anticancer research.


    1. [1]

      Zhao, F. H.; Jia, X. M.; He, Y. C.; Huang, L. W.; Yan, X. Q. Syntheses and magnetic properties of three transition metal complexes based on 4΄-p-tolyl-2, 2΄: 6΄, 2΄΄-terpyridine and SCN. Polyhedron 2019, 173, 114–124.

    2. [2]

      Liu, Y. T.; Yang, L. S.; Yin, D. W.; Dang, Y.; Yang, L. Solvent-free synthesis, characterization, biological activity of Schiff bases and their metal(Ⅱ) complexes derived from ferrocenyl chalcone. J. Organomet. Chem. 2019, 899, 120903. doi: 10.1016/j.jorganchem.2019.120903

    3. [3]

      Marichev, K. O.; Patil, S. A.; Bugarin, A. Recent advances in the synthesis, structural diversity, and applications of mesoionic 1, 2, 3-triazol-5-ylidene metal complexes. Tetrahedron 2018, 74, 2523–2546. doi: 10.1016/j.tet.2018.04.013

    4. [4]

      Feng, Y. Q.; Bi, D. Q.; Hu, Y. L.; Zhong, Z. G. Ionothermal synthesis, crystal structure and antibacterial activities of a new 3d-4f hetero-metallic compound containing two kinds of ligands. Chin. J. Struct. Chem. 2015, 34, 1598–1605.

    5. [5]

      Mallela, R.; Konakanchi, R.; Guda, R.; Munirathinam, N.; Gandamalla, D.; Yellu, N. R. Zn(Ⅱ), Cd(Ⅱ) and Hg(Ⅱ) metal complexes of 2-aminonicotinaldehyde: synthesis, crystal structure, biological evaluation and molecular docking study. Inorg. Chim. Acta 2018, 469, 66–75. doi: 10.1016/j.ica.2017.08.042

    6. [6]

      Roozbahani, P.; Salehi, M.; Malekshah, R. E.; Kubicki, M. Synthesis, crystal structure, electrochemical behavior and docking molecular of poly-nuclear metal complexes of Schiff base ligand derived from 2-amino benzyl alcohol. Inorg. Chim. Acta 2019, 496, 119022. doi: 10.1016/j.ica.2019.119022

    7. [7]

      Qiao, Y.; Zhou, Y. F.; Guan, W. S.; Liu, L. H.; Liu, B.; Che, G. B. Syntheses, structures, and photocatalytic properties of two new one-dimensional chain transition metal complexes with mixed N, O-donor ligands. Inorg. Chim. Acta 2017, 466, 291–297. doi: 10.1016/j.ica.2017.06.018

    8. [8]

      Chai, X. C.; Gao, X. N.; Li, H.; Zhang, H. H.; Han, Q. P. Two coordination novel polymers based on a flexible ligand N, N΄-diacetic acid imidazolium. Chin. J. Struct. Chem. 2017, 36, 463–470.

    9. [9]

      Fan, C. B.; Wang, Y. L.; Xu, W. Y.; Liu, Q. Y. Ionothermal synthesis and characterization of a three-dimensional anionic zinc-5-sulfoisophthalate framework charge-balanced with the 1-Ethyl-3-methylimidazolium. Chin. J. Struct. Chem. 2016, 35, 77–84.

    10. [10]

      Deng, G. G.; Zhou, B.; Wang, J.; Chen, Z.; Gong, L.; Gong, Y. X. Synthesis and antitumor activity of novel steroidal imidazolium salt derivatives. Eur. J. Med. Chem. 2019, 168, 232–252. doi: 10.1016/j.ejmech.2019.02.025

    11. [11]

      Gan, Z. J.; Tian, Q. Q.; Shang, S. Q.; Luo, W.; Dai, Z. S.; Wang, H. J.; Li, D.; Wang, X. T.; Yuan, J. Y. Imidazolium chloride-catalyzed synthesis of benzimidazoles and 2-substituted benzimidazoles from o-phenylenediamines and DMF derivatives. Tetrahedron 2018, 74, 7450–7456. doi: 10.1016/j.tet.2018.11.014

    12. [12]

      Juan, B.; Jingan, Z. Study and application of benzimidazolium substituted amines and their metal complexes. J. Guangdong Trace Element Science 2008, 15, 1–6.

    13. [13]

      Yuan, W. G.; Ting, W.; Zhang, H. L.; Zhao, B.; Xiong, F.; Jing, L. H.; Qin. D. B. Two amine-tethered imidazolium NHC Ni(Ⅱ) complexes: synthesis, structure and catalytic activity. Chin. J. Struct. Chem. 2014, 33, 325–332.

    14. [14]

      Alfaif, M. Y.; Elbehairi, S. E. I.; Hafez, H. S. Spectroscopic exploration of binding of new imidazolium-based palladium(Ⅱ) saldach complexes with CT-DNA as anticancer agents against HER2/neu overexpression. J. Mol. Struct. 2019, 1191, 118–128. doi: 10.1016/j.molstruc.2019.04.119

    15. [15]

      Zhou, Q. H.; Yang, F. S. Spectroscopic study on the interaction mode of bis-(2-benzimidazolyl methylene) amine copper(Ⅱ) complex with DNA. J. Chem. 2005, 63, 71–74.

    16. [16]

      Zhou, Q. H.; Yang, F. S. Hydrolysis and cleavage of(Ⅱ) complex with bis(2-benzimidazolyl methylene) amine manganese complex. J. Chem. 2005, 21, 960–964.

    17. [17]

      Gamov, G. A.; Zavalishin, M. N.; Sharnin, V. A. Comment on the frequently used method of the metal complex-DNA binding constant determination from UV-Vis data. Spectrochimica Acta A 2019, 206, 160–164. doi: 10.1016/j.saa.2018.08.009

    18. [18]

      Fathima, S. S. A.; Paulpandiyan, R.; Nagarajan, E. R. Expatiating biological excellence of aminoantipyrine derived novel metal complexes: combined DNA interaction, antimicrobial, free radical scavenging studies and molecular docking simulations. J. Mol. Catal. A-Chem. 2019, 1178, 179–191.

    19. [19]

      Hegde, D.; Naik, G. N.; Vadavi, R. S.; Kumar, V. S.; Barretto, D. A.; Gudasi, K. B. Transition metal complexes of N΄-(2-(hydroxyimino) propanoyl) isonicotinohydrazide: synthesis, characterization, DNA interaction and anticancer evaluation. Inorg. Chim. Acta 2017, 461, 301–315. doi: 10.1016/j.ica.2017.02.034

    20. [20]

      Li, S.; Miao, T. F.; Fu, X. L.; Ma, F.; Gao, H.; Zhang, G. P. Theoretical study on the DNA interaction properties of copper(Ⅱ) complexes. Comput. Biol. Chem. 2019, 80, 244–248. doi: 10.1016/j.compbiolchem.2019.03.021

    21. [21]

      Marzieh, A.; Masoud, T. M. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(Ⅱ) complexes. Spectrochimica Acta A 2015, 150, 390–402. doi: 10.1016/j.saa.2015.05.076

    22. [22]

      Sharma, N. K.; Ameta, R. K.; Singh, M. Spectrophotometric and physicochemical studies of newly synthesized anticancer Pt(Ⅳ) complexes and their interactions with CT-DNA. J. Mol. Liq. 2016, 222, 752–761. doi: 10.1016/j.molliq.2016.07.101

    23. [23]

      Kumar, A.; Kumar, A.; Gupta, R. K.; Paitandi, R. P.; Singh, K. B. Cationic Ru(Ⅱ), Rh(Ⅲ) and Ir(Ⅲ) complexes containing cyclic π-perimeter and 2-aminophenyl benzimidazole ligands: synthesis, molecular structure, DNA and protein binding, cytotoxicity and anticancer activity. J. Organomet. Chem. 2016, 801, 68–79. doi: 10.1016/j.jorganchem.2015.10.008

    24. [24]

      Dehkhodaei, M.; Sahihi, M.; Rudbari, H. A.; Gharaghani, S.; Azadbakht, R.; Taheri, S.; Kajani, A. A. Studies of DNA- and HSA-binding properties of new nano-scale green synthesized Ni(Ⅱ) complex as anticancer agent using spectroscopic methods, viscosity measurement, molecular docking, MD simulation and QM/MM. J. Mol. Liq. 2017, 248, 24–35. doi: 10.1016/j.molliq.2017.10.044

    25. [25]

      Hou, T. T.; Bian, J. Y.; Yue, X. R.; Yue, S. M.; Ma, J. F. Synthesis, crystal structure, photoluminescence and theoretical studies of a series of copper(Ⅰ) compounds based on imidazole derivatives. Inorg. Chim. Acta 2013, 394, 15–20. doi: 10.1016/j.ica.2012.07.020

    26. [26]

      Hou, T. T.; Yue, S. M.; Yue, X. R.; Ma, J. F. Syntheses, crystal structures, and properties of nickel and cadmium complexes containing imidazole derivatives. J. Coord. Chem. 2012, 65: 22, 3895–3902.

    27. [27]

      Yue, X. R.; Chen, Y. N.; Yang, G. C.; Yue, S. M.; Su, Z. M. Synthesis, crystal structures and DNA-binding properties of Cd(Ⅱ), Cu(Ⅱ) and Ni(Ⅱ) complexes with 2-(2-pyridyl) benzothiazole. Synth. Met. 2015, 200, 1–6. doi: 10.1016/j.synthmet.2014.12.022

    28. [28]

      Yue, S. M.; Qi, S.; Li, Y. H.; Yang, Y. Syntheses, crystal structures and DNA-binding properties of Zn(Ⅱ), Ni(Ⅱ) and Co(Ⅱ) compounds containing thiazole derivatives. J. Struct. Chem. 2018, 37, 1945–1959.

    29. [29]

      Sheldrick, G. M. Acta Crystallog A 2008, 64, 112. doi: 10.1107/S0108767307043930

    30. [30]

      Sheldrick, G. M. Acta Cryst. 2015, C71, 3–8.

    31. [31]

      Schmidt, M. W.; Baldridge, K. K.; Boatz, J. A.; Elbert, S. T.; Gordon, M. S. General atomic and molecular electronic structure system. J. Comput. Chem. 1993, 14, 1347–1363. doi: 10.1002/jcc.540141112

    32. [32]

      Guo, Q.; Zhang, Z. H.; Song, Y. T.; Liu, S.; Gao, W.; Qiao, H.; Guo, L. L. Investigation on interaction of DNA and several cationic surfactants with different head groups by spectroscopy, gel electrophoresis and viscosity technologies. Chemosphere 2017, 168, 599–605. doi: 10.1016/j.chemosphere.2016.11.019

    33. [33]

      Bonacorso, H. G.; Calheiro, T. P.; Iglesias, B. A.; Silveira, C. H. D. Multinuclear NMR spectroscopy, photophysical, electrochemical and DNA-binding properties of fluorinated 1, 8-naphthyridine-based boron heterocycles. J. Fluorine Chem. 2018, 205, 8–14. doi: 10.1016/j.jfluchem.2017.11.006

    34. [34]

      Silveira, C. H. D.; Garoforo, E. N.; Chaves, O. A.; Gonçalves, P. F. B.; Streit, L. Synthesis, spectroscopy, electrochemistry and DNA interactive studies of meso-tetra (1-naphthyl) porphyrin and its metal complexes. Inorg. Chim. Acta 2018, 482, 542–553. doi: 10.1016/j.ica.2018.06.052

    35. [35]

      Ding, P. P.; Wang, Y.; Kou, H. Z.; Li, J. F.; Shi, B. X. Synthesis of heterobinuclear Cu(Ⅱ)-Ni(Ⅱ) complex: structure, CT-DNA interaction, hydrolytic function and antibacterial studies. J. Mol. Struct. 2019, 1196, 836–843. doi: 10.1016/j.molstruc.2019.06.081

    36. [36]

      Daravath, S.; Vamsikrishna, N.; Ganji, N.; Venkateswarlu, K. Synthesis, characterization, DNA binding ability, nuclease efficacy and biological evaluation studies of Co(Ⅱ), Ni(Ⅱ) and Cu(Ⅱ) complexes with benzothiazole Schiff base. Chemical Data Collections 2018, 17–18, 159–168.

    37. [37]

      Goswami, S.; Ray, S.; Sarkar, M. Spectroscopic studies on the interaction of DNA with the copper complexes of NSAIDs lornoxicam and isoxicam. International Int. J. Biol. Macromol. 2016, 93, 47–56. doi: 10.1016/j.ijbiomac.2016.08.025

    38. [38]

      Bandyopadhyay, N.; Pradhan, A. B.; Das, S.; Lu, L.; Zhu, M. Synthesis, structure, DFT calculations, electrochemistry, fluorescence, DNA binding and molecular docking aspects of a novel oxime based ligand and its palladium(Ⅱ) complex. J. Photoch. Photobio. B 2016, 160, 336–346. doi: 10.1016/j.jphotobiol.2016.04.026

    39. [39]

      Alreja, P.; Kaur, N. DNA and copper(Ⅱ) governed fluorescence tuning of phenanthroline possessing Ru(Ⅱ) complex. Interplay of electrostatic interactions. Inorg. Chem. Commun. 2017, 77, 51–54. doi: 10.1016/j.inoche.2017.01.033

    40. [40]

      Palanimuthu, D.; Samuelson, A. G. Dinuclear zinc bis(thiosemicarbazone) compounds: synthesis, in vitro anticancer activity, cellular uptake and DNA interaction study. Inorg. Chim. Acta 2013, 408, 152–161. doi: 10.1016/j.ica.2013.09.014

    41. [41]

      Keypour, H. K.; Forouzandeh, F.; Salehzadeh, S.; Hajibabaei, F.; Feizi, S.; Karamian, R. DNA binding studies and antibacterial properties of a new Schiff base ligand containing homopiperazine and products of its reaction with Zn(Ⅱ), Cu(Ⅱ) and Co(Ⅱ) metal ions: X-ray crystal structure of Cu(Ⅱ) and Zn(Ⅱ) complexes. Polyhedron 2019, 170, 584–592. doi: 10.1016/j.poly.2019.06.023

    42. [42]

      Saeidifar, M.; Mirzaei, H.; Nasab, N. A.; Torshizi, H. M. Mononuclear Pd(Ⅱ) complex as a new therapeutic agent: synthesis, characterization, biological activity, spectral and DNA binding approaches. J. Mol. Struct. 2017, 1148, 339–346. doi: 10.1016/j.molstruc.2017.06.139

    43. [43]

      Shankaraiah, N.; Jadala, C.; Nekkanti, S.; Senwar, K. R.; Nagesh, N.; Shrivastava, S. Design and synthesis of C3-tethered 1, 2, 3-triazolo-β-carboline derivatives: anticancer activity, DNA-binding ability, viscosity and molecular modeling studies. Bioorg. Chem. 2016, 64, 42–50. doi: 10.1016/j.bioorg.2015.11.005

  • Figure 1  Molecular structure of complex 1 at 50% displacement ellipsoids

    Figure 2  Packing diagram of complex 1 in a unit cell viewed along the a axis

    Figure 3  Molecular structure of complex 2 at 50% displacement ellipsoids

    Figure 4  Packing diagram of complex 2 in a unit cell viewed along the a axis

    Figure 5  Molecular structure of complex 3 at 50% displacement ellipsoids

    Figure 6  Packing diagram of complex 3 in a unit cell viewed along the c axis

    Figure 7  Molecular structure of complex 4 at 50% displacement ellipsoids

    Figure 8  Packing diagram of complex 4 in a unit cell viewed along the a axis

    Figure 9  TG curves of complexes 1~4

    Figure 10  Simulated and experimental XRPD patterns of complexes 1~4

    Figure 11  Absorption spectra of (a) [Cd(pbm)(odc)2], (b) [Co(pbm)(odc)2], (c) [Cu(pbm)(odc)2] and (d) [Zn(pbm)(odc)2] in tris-HCl buffer (pH 7.0) in the absence and presence of increasing the amount of DNA at room temperature. Inset: arrow shows change in intensity with increasing the concentration of DNA

    Figure 12  Emission spectra of (a) [Cd(pbm)(odc)2], (b) [Co(pbm)(odc)2], (c) [Cu(pbm)(odc)2] and (d) [Zn(pbm)(odc)2] in tris-HCl buffer (pH 7.0) in the presence and absence of CT-DNA at room temperature. Arrow shows change in intensity with increasing the concentration of DNA

    Figure 13  Relative viscosity of CT-DNA upon addition of increasing the amounts of complexes 1~4 (r = 0.0~1.0). η is the viscosity of DNA in the presence of complex, and η0 is the viscosity of DNA alone

    Table 1.  Crystal Data and Structure Refinement for 1~4

    Complexes 1 2 3 4
    CCDC 1924089 1938100 1938101 1924090
    Chemical formula C26H17CdN3O5 C26H17CoN3O5 C26H17CuN3O5 C26H17N3O5Zn
    Temperature (K) 296.15 173.0 187.49 293(2)
    Mr 563.82 510.35 514.96 516.79
    Crystal system Monoclinic Monoclinic Monoclinic Monoclinic
    Space group P21/n P21/n P21/c P21/n
    a (Å) 7.4963(4) 7.3081(9) 13.1636(10) 7.4336(8)
    b (Å) 18.3015(10) 18.501(3) 15.3767(10) 18.470(2)
    c (Å) 16.5769(9) 16.257(2) 11.3600(8) 16.2706(18)
    α (º) 90 90 90 90
    β (º) 98.3510(10) 99.310(5) 100.141(4) 99.863(2)
    γ (º) 90 90 90 90
    Volume (Å3) 2250.1(2) 2169.0(5) 2263.5 2200.9(4)
    Z 4 4 4 4
    Dc (g·cm-3) 1.664 1.563 1.511 1.560
    F(000) 1128.0 1044.0 1052.0 1056.0
    2θ range for data collection 5.69 to 51.424 5.536 to 50.12 8.924 to 130.15 3.36 to 49.364
    Reflections collected/unique 13616/4273(Rint = 0.0610) 21572/3835(Rint = 0.0881) 13027/3757(Rint = 0.0532) 12201/3754(Rint = 0.1168)
    Goodness-of-fit on F2 1.027 1.055 1.129 1.020
    Final R indexes (I > 2σ(I)) R = 0.0518, wR = 0.1222 R = 0.0624, wR = 0.1293 R = 0.0851, wR = 0.1790 R = 0.0667, wR = 0.1717
    Final R indexes (all data) R = 0.0918, wR = 0.1417 R = 0.0927, wR = 0.1428 R = 0.1106, wR = 0.1942 R = 0.1639, wR = 0.2547
    下载: 导出CSV

    Table 2.  Concentration Ratio of the Mixed Solution

    Material number Tris (μL) DNA(μL) Complex (μL)
    1 2700 0 300
    2 2400 300 300
    3 2100 600 300
    4 1800 900 300
    5 1500 1200 300
    6 1200 1500 300
    下载: 导出CSV

    Table 3.  Selected Bond Lengths (Å) and Bond Angles (°) of Complexes 1~4

    Complex 1 Complex 2 Complex 3 Complex 4
    Bond Dist. Bond Dist. Bond Dist. Bond Dist.
    Cd(1)–O(1) 2.256(4) Co(1)–O(1) 2.142(3) Cu(1)–O(1) 1.856(5) Zn(1)–O(1) 2.132(6)
    Cd(1)–O(2) 2.286(4) Co(1)–O(2) 2.108(3) Cu(1)–O(4)#1 2.092(6) Zn(1)–O(2) 2.158(7)
    Cd(1)–O(4)#1 2.372(4) Co(1)–O(4)#1 2.202(3) O(1)–Cu(1A)#2 1.684(7) Zn(1)–O(4)#1 2.145(6)
    Cd(1)–O(5)#1 2.307(4) Co(1)–O(5)#1 2.126(3) O(5)–Cu(1A)#2 2.408(7) Zn(1)–O(5)#1 2.247(7)
    Cd(1)–N(1) 2.369(6) Co(1)–N(1) 2.169(5) Cu(1)–N(1) 2.051(6) Zn(1)–N(1) 2.045(7)
    Cd(1)–N(2) 2.236(5) Co(1)–N(2) 2.046(4) Cu(1)–N(2) 1.966(7) Zn(1)–N(3) 2.216(9)
    Angle (°) Angle (°) Angle (°) Angle (°)
    C(13)–O(1)–Cd(1) 91.1(4) C(13)–O(1)–Co(1) 87.8(3) C(13)–O(1)–Cu(1) 102.9(4) C(1)–O(1)–Zn(1) 90.1(6)
    C(13)–O(2)–Cd(1) 89.8(4) C(13)–O(2)–Co(1) 89.4(3) C(26)–O(4)–Cu(1)#2 99.3(5) C(1)–O(2)–Zn(1) 88.2(6)
    C(1)–N(1)–Cd(1) 126.4(5) C(1)–N(1)–Co(1) 129.0(4) N(1)–Cu(1)–O(4)#1 163.7(3) C(15)–N(1)–Zn(1) 136.6(7)
    C(5)–N(1)–Cd(1) 114.7(4) C(5)–N(1)–Co(1) 113.7(3) C(5)–N(1)–Cu(1) 113.2(3) C(21)–N(1)–Zn(1) 114(6)
    C(6)–N(2)–Cd(1) 113.8(4) C(6)–N(2)–Co(1) 113.0(3) C(1)–N(1)–Cu(1) 126.8(3) C(22)–N(3)–Zn(1) 112.5(7)
    C(7)–N(2)–Cd(1) 137.5(4) C(7)–N(2)–Co(1) 138.8(3) C(6)–N(2)–Cu(1) 112.0(10) C(26)–N(3)–Zn(1) 128.7(7)
    O(1)–Cd(1)–N(1) 117.74(16) O(1)–Co(1)–N(1) 92.03(15) C(7)–N(2)–Cu(1) 142.3(6) O(1)–Zn(1)–N(3) 109.7(3)
    O(2)–Cd(1)–N(1) 93.88(17) O(2)–Co(1)–N(1) 105.96(14) O(1)–Cu(1)–N(1) 92.1(2) O(2)–Zn(1)–N(3) 91.9(3)
    O(2)–Cd(1)–N(1) 93.88(17) N(2)–Co(1)–O(1) 159.98(15) O(1)–Cu(1)–N(2) 153.5(2) N(1)–Zn(1)–O(1) 102.7(3)
    N(2)–Cd(1)–O(2) 155.42(18) N(2)–Co(1)–O(2) 103.22(15) N(2)–Cu(1)–N(1) 81.6(3) N(1)–Zn(1)–O(2) 156.7(3)
    N(2)–Cd(1)–N(1) 72.96(18) N(2)–Co(1)–N(1) 78.38(16) C(6)–N(2)–C(7) 105.6(10) N(1)–Zn(1)–N(3) 77.5(3)
    O(1)–Cd(1)–O(2) 57.63(15) O(2)–Co(1)–O(1) 62.24(12) C(8)–N(3)–C(6) 106.8(9) O(1)–Zn(1)–O(2) 61.1(3)
    下载: 导出CSV
  • 加载中
计量
  • PDF下载量:  2
  • 文章访问数:  1546
  • HTML全文浏览量:  57
文章相关
  • 发布日期:  2020-02-01
  • 收稿日期:  2019-10-09
  • 接受日期:  2019-11-27
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章